Raymond James Financial Inc Ptc Therapeutics, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 48,728 shares of PTCT stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,728Holding current value
$2.43 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
231Shares Held
78.1MCall Options Held
144KPut Options Held
54.8K-
Vanguard Group Inc Valley Forge, PA9.13MShares$454 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$393 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$387 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$368 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$360 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.56B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...